Calliditas Therapeutics
ongoing pivotal phase clinical trial designed to confirm phase results | Calliditas Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
16 of 38
Related slides by other companies
Oculis
Investor Conference
June 2023
stage results stage trial next step commence stage of phase program to support filing of for treatment | Oculis
MaxCyte
Investor Presentation
May 2023
example typical single product revenues from a representative license deal | MaxCyte
Adagio Therapeutics
Investor Conference
June 2023
is positioned to potentially fulfill a large unmet need | Adagio Therapeutics
23andMe
Investor Presentation
January 2024
next steps | 23andMe
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights